Country: United Kingdom
Bahasa: Inggeris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Quetiapine fumarate
Kent Pharma (UK) Ltd
N05AH04
Quetiapine fumarate
25mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100
Quetiapine contains the active substance quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapine can be used to treat several illnesses, such as: • Schizophrenia: where you may hear or feel things that are not there, believe things that are not true or feel unusually suspicious, anxious, confused, guilty, tense or depressed. • Mania: where you may feel very excited, elated, agitated, enthusiastic or hyperactive or have poor judgment including being aggressive or disruptive. • Bipolar depression: where you feel sad. You may find that you feel depressed, feel guilty, lack energy, lose your appetite or can’t sleep. Your doctor may continue to prescribe Quetiapine even when you are feeling better. DO NOT TAKE QUETIAPINE • If you are allergic to quetiapine or any of the other ingredients of this medicine (listed in section 6) • If you are taking any of the following medicines: – some medicines used to treat HIV infections – azole medicines (medicines used to treat fungal infections) – erythromycin or clarithromycin (medicines used to treat bacterial infections) – nefazodone (medicine used to treat depression). Do not take Quetiapine if the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Quetiapine. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Quetiapine: • if you, or someone in your family, have or have had any heart problems, for example heart rhythm problems, weakening of the heart muscle or inflammation of the heart or if you are taking any medicines that may have an impact on the way your heart beats. • if you have low blood pressure. • if you have had a stroke, especially if you are elderly. • if you have problems with your liver. • if you have ever had a fit (seizure). • if you have diabetes or have a risk of getting diabetes. If you do, your doctor may check your blood sugar levels while you are taking Quetiapine. • if you know that you have had low levels of white blood cells in the Baca dokumen lengkap
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Quetiapine 25 mg Film-coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 25 mg quetiapine (as quetiapine fumarate). Excipient(s) with known effect Each film-coated tablet contains 14 mg of lactose and 0.031 mg of sunset yellow FCF aluminium lake (E110). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Light-orange, round, biconvex, film-coated tablet, engraved “25” on one side and plain on the other 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Quetiapine is indicated for: • treatment of schizophrenia. • treatment of bipolar disorder: o For the treatment of moderate to severe manic episodes in bipolar disorder o For the treatment of major depressive episodes in bipolar disorder o For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Different dosing schedules exist for each indication. It must therefore be ensured that patients receive clear information on the appropriate dosage for their condition. _Adults _ _ _ For the treatment of schizophrenia For the treatment of schizophrenia, quetiapine should be administered twice a day. The total daily dose for the first four days of therapy is 50 mg (Day 1), 100 mg (Day 2), 200 mg (Day 3) and 300 mg (Day 4). From Day 4 onwards, the dose should be titrated to the usual effective dose of 300 to 450 mg/day. Depending on the clinical response and tolerability of the individual patient, the dose may be adjusted within the range 150 to 750 mg/day. For the treatment of moderate to severe manic episodes in bipolar disorder For the treatment of manic episodes associated with bipolar disorder, quetiapine should be administered twice a day. The total daily dose for the first four days of therapy is 100 mg (Day 1), 200 mg (Day 2), 300 mg (Day 3) and 400 mg (Day 4). Further dos Baca dokumen lengkap